Evidence map›Paper›PMID 39422521›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Chronotypes in middle-aged women with polycystic ovary syndrome: A population-based study.

Linnea Kroneld, Päivi Polo-Kantola, Meri-Maija Ollila, Riikka K Arffman, Elisa Hurskainen, Laure Morin-Papunen, Varpu Jokimaa, Terhi T Piltonen

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Linnea KroneldDepartment of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0002-7069-3952
Päivi Polo-KantolaDepartment of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0003-0665-0306
Meri-Maija OllilaDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Research Unit of Clinical Medicine, Medical Research Center, Oulu, Finland.ORCID 0000-0002-6794-0369
Riikka K ArffmanDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Research Unit of Clinical Medicine, Medical Research Center, Oulu, Finland.ORCID 0000-0003-3277-9293
Elisa HurskainenDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Research Unit of Clinical Medicine, Medical Research Center, Oulu, Finland.ORCID 0000-0002-1030-4417
Laure Morin-PapunenDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Research Unit of Clinical Medicine, Medical Research Center, Oulu, Finland.ORCID 0000-0001-5987-7534
Varpu JokimaaDepartment of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0002-6405-488X
Terhi T PiltonenDepartment of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Research Unit of Clinical Medicine, Medical Research Center, Oulu, Finland.ORCID 0000-0002-9921-7300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCircadian rhythm disruption has been associated with the risk of polycystic ovary syndrome (PCOS), as the evening chronotype (EC) shares several traits with PCOS, including metabolic disorders, cardiovascular diseases, and psychiatric disorders. It has been suggested that the biological clock could be targeted with new, preventive, and therapeutic strategies for PCOS in women with biorhythm disorders. We evaluated inner circadian rhythmicity in middle-aged women with PCOS in a population-based setting, focusing on whether women with PCOS and an EC have a specific subtype in relation to their clinical characteristics. MATERIAL AND

methodsThe data derived from the Northern Finland Birth Cohort, a population-based longitudinal birth cohort of 12 058 individuals born in 1966. We compared the circadian phenotype between 314 women with PCOS (according to the Rotterdam criteria) and 1248 women without PCOS at age 46 years using the validated Finnish shortened 6-item Morningness-Eveningness Questionnaire (sMEQ) and the single-item self-assessed morningness-eveningness question.

resultsPCOS was not associated with the EC by the sMEQ (p = 0.495) or self-assessment (p = 0.303). The self-assessed morningness-eveningness values differed from the sMEQ chronotype distribution (p < 0.001), nevertheless, the most frequent chronotype was the intermediate chronotype (IC) determined by both chronotyping methods (sMEQ PCOS 47.7% vs. 45.2% non-PCOS; self-assessment PCOS 66.5% vs. 68.4% non-PCOS). The hyperandrogenic PCOS phenotypes A-C did not differ from the non-hyperandrogenic phenotype D as for the chronotype (p = 0.271). The EC was associated in both groups with depressive and anxiety symptoms (PCOS p = 0.012, non-PCOS p < 0.001) and the use of sleep medication (PCOS p = 0.017, non-PCOS p < 0.001).

conclusionsThe EC was not over-represented in middle-aged women with PCOS or in the hyperandrogenic PCOS phenotypes A-C in our study. This does not support the need for chronotyping in the comprehensive assessment of women with PCOS. However, as chronotypes tend to change with aging, cross-sectional studies in different age groups are warranted to draw conclusions on the role of chronotypes in PCOS and the associated metabolic risks.

Indexed as

Circadian RhythmPolycystic Ovary SyndromeChronotypeFemaleFinlandHumansLongitudinal StudiesMiddle AgedPhenotypeSurveys and Questionnaireschronotypecircadian rhythmMEQmorningness‐eveningnessPCOSpolycystic ovary syndrome

Identifiers

PMID39422521
PMCPMC11610004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.